Polymorphism of the β2-adrenoceptor and the response to long-term β2-agonist therapy in asthma

European Respiratory Journal

Volumn 11, Issue 3, 1998, Pages 589-593

  Hancox, R J ^a   Sears, M R ^b   Taylor, D R ^a,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

2 agonist; 2 receptor polymorphism; Asthma

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; GLYCINE;

AMINO ACID SEQUENCE; ARTICLE; ASTHMA; BETA ADRENERGIC STIMULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; DOWN REGULATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; POLYMERASE CHAIN REACTION; TIME;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ASTHMA; DOUBLE-BLIND METHOD; DOWN-REGULATION; FENOTEROL; GENOTYPE; GLUTAMIC ACID; GLYCINE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; TIME FACTORS;

EID: 0031597001     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391-1396.
2. Taylor DR, Sears MR, Herbison GP, et al. Regular inhaled β-agonist in asthma: effects on exacerbations and lung function. Thorax 1993; 48: 134-138.
3. Gibson GJ, Greenacre JK, König P, et al. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest 1978; 72: 199-206.
4. Vathenen AS, Knox AJ, Higgens BG, Britton JR, Tattersfield AE. Rebound increase in bronchial hyperresponsiveness after treatment with inhaled terbutaline. Lancet 1988; 1: 554-558.
5. 2-agonists in asthma. N Engl J Med 1992; 327: 1204-1208.
6. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334-339.
7. 2-receptor impart distinct agonist-promoted regulatory properties. Biochem 1994; 33: 9414-9419.
8. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 25-33.
9. 2-adrenergic receptor in nocturnal and nonnocturnal asthma. J Clin Invest 1995; 95; 1635-1641.
10. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995; 345: 1213-1214.
11. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997; 350: 995-999.
12. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235-243.
13. Harvey JE, Tattersfield AE. Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax 1982; 37: 280-287.
14. Tashkin DP, Conolly ME, Deutsch RI, et al. Subsensitization of beta-adrenoreceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Respir Dis 1982; 125: 185-193.
15. Lipworth BJ, Struthers AD, McDevitt DG. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis 1989; 140: 586-592.
16. Larsson S, Svedmyr N, Thiringer G. Lack of bronchial adrenoceptor resistance in asthmatics during long-term treatment with terbutaline. J Allergy Clin Immunol 1977; 59: 93-100.
17. van Schayck CP, Graafsma SJ, Visch MB, et al. Increased bronchial hyperresposiveness after inhaling salbutamol during 1 yr is not caused by subsensitization to salbutamol. J Allergy Clin Immunol 1990; 96: 793-800.
18. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152: 838-860.